![These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA® (dapagliflozin) tablets, for oral useInitial U.S. Approval: 2014 These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA® (dapagliflozin) tablets, for oral useInitial U.S. Approval: 2014](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=farxiga-5mg-30s.jpg&id=710641)
These highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for FARXIGA. FARXIGA® (dapagliflozin) tablets, for oral useInitial U.S. Approval: 2014
![FDA Approves Farxiga For Adults With HF With Reduced Ejection Fraction - American College of Cardiology FDA Approves Farxiga For Adults With HF With Reduced Ejection Fraction - American College of Cardiology](https://www.acc.org//-/media/Non-Clinical/Images/2019/11/CARDIOLOGY/Farxiga-1200x800.jpg)
FDA Approves Farxiga For Adults With HF With Reduced Ejection Fraction - American College of Cardiology
![FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial | DAIC FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial | DAIC](http://www.dicardiology.com/sites/default/files/Farxiga_1.jpeg)